Arbs side effects
Pro Research Analysisby 
Searched over 200M research papers
Side Effects of Angiotensin Receptor Blockers (ARBs)
Common Side Effects of ARBs
Angiotensin receptor blockers (ARBs) are generally well-tolerated medications used primarily for the treatment of hypertension and related cardiovascular conditions. Common side effects reported in clinical trials include headache, lightheadedness, dizziness, nausea, and diarrhea, which are typically mild to moderate in severity . These side effects are less frequent compared to those associated with angiotensin-converting enzyme inhibitors (ACEIs), particularly the incidence of cough 12.
Comparison with ACE Inhibitors
One of the significant advantages of ARBs over ACE inhibitors is the lower incidence of cough. ACE inhibitors are known to cause a persistent dry cough in a substantial number of patients, which can lead to discontinuation of therapy. In contrast, ARBs do not increase bradykinin levels, which is the primary cause of cough in ACE inhibitor therapy . Additionally, angioedema, a potentially serious side effect, is less common with ARBs compared to ACE inhibitors, although cross-reactivity can occur in patients who have experienced angioedema with ACE inhibitors 13.
Serious Adverse Effects
While ARBs are generally safe, they are not without serious adverse effects. Angioedema, although rare, can occur and is a known complication of ARB therapy. Patients with a history of angioedema related to ACE inhibitors should be monitored closely if switched to ARBs . Hypotension, particularly first-dose hypotension, is another concern, especially in patients who are volume-depleted or on high doses of diuretics .
Renal Function and Electrolyte Imbalance
ARBs can affect renal function, leading to an increase in serum creatinine and potassium levels. This is particularly important in patients with pre-existing renal impairment or those taking other medications that affect renal function. Regular monitoring of renal function and electrolytes is recommended to prevent complications such as hyperkalemia and acute kidney injury .
Quality of Life and Patient Adherence
Quality of life (QOL) is an essential factor in the long-term management of hypertension. Studies have shown that patients switched from other antihypertensive agents to ARBs report improvements in QOL measures, which can enhance adherence to treatment regimens . This is likely due to the lower incidence of bothersome side effects such as cough and the overall tolerability of ARBs.
Manufacturing Contamination Concerns
Recent concerns have been raised about manufacturing contaminants in certain batches of ARBs, specifically the presence of suspected carcinogenic substances. This has led to recalls and increased scrutiny of the manufacturing processes for these medications . Patients and healthcare providers should stay informed about these issues and report any adverse reactions promptly.
Conclusion
ARBs are a well-tolerated class of antihypertensive medications with a favorable side effect profile compared to ACE inhibitors. Common side effects are generally mild, and serious adverse effects such as angioedema and renal impairment are relatively rare but require monitoring. The lower incidence of cough and improvements in quality of life make ARBs a preferred option for many patients. However, recent concerns about manufacturing contaminants highlight the need for vigilance in monitoring and reporting adverse drug reactions.
Sources and full results
Most relevant research papers on this topic